Trial of INI-4001 in Patients With Advanced Solid Tumours

Clinical trial NCT06302426 · RECRUITING

Trial details

NCT number: NCT06302426
Sponsor: Inimmune Corporation
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-07-01
Primary completion: 2026-10-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.